Cargando…

Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases

BACKGROUND: Myocardial fibrosis is an important pathophysiologic mechanism of cardiac involvement that leads to increased mortality in patients with autoimmune diseases (AIDs). The aim of this study was to evaluate the association between myocardial strain from speckle-tracking echocardiography (STE...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Fuwei, Li, Xiao, Zhang, Dingding, Jiang, Shu, Yin, Jie, Feng, Xiaojin, Zhu, Yanlin, Liu, Yingxian, Zhu, Yuanyuan, Lai, Jinzhi, Yang, Huaxia, Fang, Ligang, Chen, Wei, Wang, Yining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899104/
https://www.ncbi.nlm.nih.gov/pubmed/35265686
http://dx.doi.org/10.3389/fcvm.2022.836942
_version_ 1784663831671209984
author Jia, Fuwei
Li, Xiao
Zhang, Dingding
Jiang, Shu
Yin, Jie
Feng, Xiaojin
Zhu, Yanlin
Liu, Yingxian
Zhu, Yuanyuan
Lai, Jinzhi
Yang, Huaxia
Fang, Ligang
Chen, Wei
Wang, Yining
author_facet Jia, Fuwei
Li, Xiao
Zhang, Dingding
Jiang, Shu
Yin, Jie
Feng, Xiaojin
Zhu, Yanlin
Liu, Yingxian
Zhu, Yuanyuan
Lai, Jinzhi
Yang, Huaxia
Fang, Ligang
Chen, Wei
Wang, Yining
author_sort Jia, Fuwei
collection PubMed
description BACKGROUND: Myocardial fibrosis is an important pathophysiologic mechanism of cardiac involvement that leads to increased mortality in patients with autoimmune diseases (AIDs). The aim of this study was to evaluate the association between myocardial strain from speckle-tracking echocardiography (STE) and fibrosis on cardiovascular magnetic resonance (CMR) and to further explore their prognostic implications in patients with AIDs. METHODS: We prospectively included 102 AIDs patients with clinically suspected cardiac involvement and 102 age- and sex-matched healthy individuals. Patients underwent CMR for evaluation of myocardial fibrosis by late gadolinium enhancement (LGE) and T1 mapping. A semiquantitative evaluation based on the extent of LGE was used to calculate the total (tLGEs) and segmental (sLGEs) LGE score. Global longitudinal strain (GLS) was evaluated by STE in all subjects. All patients were regularly followed up every 6 months. The primary endpoint was the composite incidence of all-cause death and cardiovascular hospitalization. RESULTS: Compared to healthy controls, AIDs patients had impaired GLS (−17.9 ± 5.1% vs. −21.2 ± 2.5%, p < 0.001). LGE was detected in 70% of patients. Patients with LGE presented worse GLS (−17.1 ± 5.3% vs. −19.6 ± 4.1%, p = 0.018) than those without LGE. On multivariate logistic analysis, GLS ≥ −15% was an independent predictor of LGE presence (OR = 4.98, 95%CI 1.35–18.33, p = 0.016). Moreover, a marked and stepwise impairment of segmental longitudinal strain (−19.3 ± 6.6 vs. −14.9 ± 6.5 vs. −8.9 ± 6.3, p < 0.001) was observed as sLGEs increased. During a median follow-up time of 25 months, 6 patients died, and 14 patients were hospitalized for cardiovascular reasons. Both GLS ≥ −15% (HR 3.56, 95%CI 1.28–9.86, p = 0.015) and tLGEs ≥ 6 (HR 4.13, 95%CI 1.43–11.92, p = 0.009) were independently associated with the primary endpoint. CONCLUSIONS: In AIDs patients, impaired myocardial strain on STE could reflect the presence and extent of myocardial fibrosis and provide incremental prognostic value in addition to LGE in the prediction of adverse outcomes.
format Online
Article
Text
id pubmed-8899104
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88991042022-03-08 Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases Jia, Fuwei Li, Xiao Zhang, Dingding Jiang, Shu Yin, Jie Feng, Xiaojin Zhu, Yanlin Liu, Yingxian Zhu, Yuanyuan Lai, Jinzhi Yang, Huaxia Fang, Ligang Chen, Wei Wang, Yining Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Myocardial fibrosis is an important pathophysiologic mechanism of cardiac involvement that leads to increased mortality in patients with autoimmune diseases (AIDs). The aim of this study was to evaluate the association between myocardial strain from speckle-tracking echocardiography (STE) and fibrosis on cardiovascular magnetic resonance (CMR) and to further explore their prognostic implications in patients with AIDs. METHODS: We prospectively included 102 AIDs patients with clinically suspected cardiac involvement and 102 age- and sex-matched healthy individuals. Patients underwent CMR for evaluation of myocardial fibrosis by late gadolinium enhancement (LGE) and T1 mapping. A semiquantitative evaluation based on the extent of LGE was used to calculate the total (tLGEs) and segmental (sLGEs) LGE score. Global longitudinal strain (GLS) was evaluated by STE in all subjects. All patients were regularly followed up every 6 months. The primary endpoint was the composite incidence of all-cause death and cardiovascular hospitalization. RESULTS: Compared to healthy controls, AIDs patients had impaired GLS (−17.9 ± 5.1% vs. −21.2 ± 2.5%, p < 0.001). LGE was detected in 70% of patients. Patients with LGE presented worse GLS (−17.1 ± 5.3% vs. −19.6 ± 4.1%, p = 0.018) than those without LGE. On multivariate logistic analysis, GLS ≥ −15% was an independent predictor of LGE presence (OR = 4.98, 95%CI 1.35–18.33, p = 0.016). Moreover, a marked and stepwise impairment of segmental longitudinal strain (−19.3 ± 6.6 vs. −14.9 ± 6.5 vs. −8.9 ± 6.3, p < 0.001) was observed as sLGEs increased. During a median follow-up time of 25 months, 6 patients died, and 14 patients were hospitalized for cardiovascular reasons. Both GLS ≥ −15% (HR 3.56, 95%CI 1.28–9.86, p = 0.015) and tLGEs ≥ 6 (HR 4.13, 95%CI 1.43–11.92, p = 0.009) were independently associated with the primary endpoint. CONCLUSIONS: In AIDs patients, impaired myocardial strain on STE could reflect the presence and extent of myocardial fibrosis and provide incremental prognostic value in addition to LGE in the prediction of adverse outcomes. Frontiers Media S.A. 2022-02-21 /pmc/articles/PMC8899104/ /pubmed/35265686 http://dx.doi.org/10.3389/fcvm.2022.836942 Text en Copyright © 2022 Jia, Li, Zhang, Jiang, Yin, Feng, Zhu, Liu, Zhu, Lai, Yang, Fang, Chen and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Jia, Fuwei
Li, Xiao
Zhang, Dingding
Jiang, Shu
Yin, Jie
Feng, Xiaojin
Zhu, Yanlin
Liu, Yingxian
Zhu, Yuanyuan
Lai, Jinzhi
Yang, Huaxia
Fang, Ligang
Chen, Wei
Wang, Yining
Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases
title Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases
title_full Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases
title_fullStr Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases
title_full_unstemmed Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases
title_short Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases
title_sort predictive value of echocardiographic strain for myocardial fibrosis and adverse outcomes in autoimmune diseases
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899104/
https://www.ncbi.nlm.nih.gov/pubmed/35265686
http://dx.doi.org/10.3389/fcvm.2022.836942
work_keys_str_mv AT jiafuwei predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases
AT lixiao predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases
AT zhangdingding predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases
AT jiangshu predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases
AT yinjie predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases
AT fengxiaojin predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases
AT zhuyanlin predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases
AT liuyingxian predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases
AT zhuyuanyuan predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases
AT laijinzhi predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases
AT yanghuaxia predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases
AT fangligang predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases
AT chenwei predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases
AT wangyining predictivevalueofechocardiographicstrainformyocardialfibrosisandadverseoutcomesinautoimmunediseases